vs

Side-by-side financial comparison of Hormel Foods (HRL) and Solventum (SOLV). Click either name above to swap in a different company.

Hormel Foods is the larger business by last-quarter revenue ($3.2B vs $2.0B, roughly 1.6× Solventum). Solventum runs the higher net margin — 3.2% vs -1.8%, a 4.9% gap on every dollar of revenue. On growth, Hormel Foods posted the faster year-over-year revenue change (1.5% vs -3.7%). Hormel Foods produced more free cash flow last quarter ($231.4M vs $32.0M). Over the past eight quarters, Hormel Foods's revenue compounded faster (3.1% CAGR vs -0.4%).

Hormel Foods Corporation, doing business as Hormel Foods or simply Hormel, is an American multinational food processing company founded in 1891 in Austin, Minnesota, by George A. Hormel as George A. Hormel & Company. The company originally focused on the packaging and selling of ham, sausage and other pork, chicken, beef and lamb products to consumers, adding Spam in 1937. By the 1980s, Hormel began offering a wider range of packaged and refrigerated foods.

Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024.

HRL vs SOLV — Head-to-Head

Bigger by revenue
HRL
HRL
1.6× larger
HRL
$3.2B
$2.0B
SOLV
Growing faster (revenue YoY)
HRL
HRL
+5.2% gap
HRL
1.5%
-3.7%
SOLV
Higher net margin
SOLV
SOLV
4.9% more per $
SOLV
3.2%
-1.8%
HRL
More free cash flow
HRL
HRL
$199.4M more FCF
HRL
$231.4M
$32.0M
SOLV
Faster 2-yr revenue CAGR
HRL
HRL
Annualised
HRL
3.1%
-0.4%
SOLV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HRL
HRL
SOLV
SOLV
Revenue
$3.2B
$2.0B
Net Profit
$-56.1M
$63.0M
Gross Margin
14.0%
51.4%
Operating Margin
0.1%
6.3%
Net Margin
-1.8%
3.2%
Revenue YoY
1.5%
-3.7%
Net Profit YoY
-125.5%
103.2%
EPS (diluted)
$-0.10
$0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HRL
HRL
SOLV
SOLV
Q4 25
$3.2B
$2.0B
Q3 25
$3.0B
$2.1B
Q2 25
$2.9B
$2.2B
Q1 25
$3.0B
$2.1B
Q4 24
$3.1B
$2.1B
Q3 24
$2.9B
$2.1B
Q2 24
$2.9B
$2.1B
Q1 24
$3.0B
$2.0B
Net Profit
HRL
HRL
SOLV
SOLV
Q4 25
$-56.1M
$63.0M
Q3 25
$183.7M
$1.3B
Q2 25
$180.0M
$90.0M
Q1 25
$170.6M
$137.0M
Q4 24
$220.2M
$31.0M
Q3 24
$176.7M
$122.0M
Q2 24
$189.3M
$89.0M
Q1 24
$218.9M
$237.0M
Gross Margin
HRL
HRL
SOLV
SOLV
Q4 25
14.0%
51.4%
Q3 25
16.1%
54.2%
Q2 25
16.7%
54.4%
Q1 25
15.9%
53.8%
Q4 24
16.6%
53.9%
Q3 24
16.8%
56.0%
Q2 24
17.4%
54.6%
Q1 24
17.0%
58.1%
Operating Margin
HRL
HRL
SOLV
SOLV
Q4 25
0.1%
6.3%
Q3 25
7.9%
80.6%
Q2 25
8.6%
9.9%
Q1 25
7.6%
7.3%
Q4 24
9.4%
6.6%
Q3 24
8.2%
13.2%
Q2 24
8.7%
11.7%
Q1 24
9.5%
18.9%
Net Margin
HRL
HRL
SOLV
SOLV
Q4 25
-1.8%
3.2%
Q3 25
6.1%
60.4%
Q2 25
6.2%
4.2%
Q1 25
5.7%
6.6%
Q4 24
7.0%
1.5%
Q3 24
6.1%
5.9%
Q2 24
6.6%
4.3%
Q1 24
7.3%
11.8%
EPS (diluted)
HRL
HRL
SOLV
SOLV
Q4 25
$-0.10
$0.37
Q3 25
$0.33
$7.22
Q2 25
$0.33
$0.51
Q1 25
$0.31
$0.78
Q4 24
$0.41
$0.18
Q3 24
$0.32
$0.70
Q2 24
$0.34
$0.51
Q1 24
$0.40
$1.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HRL
HRL
SOLV
SOLV
Cash + ST InvestmentsLiquidity on hand
$703.6M
$878.0M
Total DebtLower is stronger
$2.9B
$5.0B
Stockholders' EquityBook value
$7.9B
$5.0B
Total Assets
$13.4B
$14.3B
Debt / EquityLower = less leverage
0.36×
1.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HRL
HRL
SOLV
SOLV
Q4 25
$703.6M
$878.0M
Q3 25
$630.7M
$1.6B
Q2 25
$699.0M
$492.0M
Q1 25
$866.4M
$534.0M
Q4 24
$766.6M
$762.0M
Q3 24
$561.9M
$772.0M
Q2 24
$1.5B
$897.0M
Q1 24
$981.9M
$996.0M
Total Debt
HRL
HRL
SOLV
SOLV
Q4 25
$2.9B
$5.0B
Q3 25
$2.9B
$5.1B
Q2 25
$2.9B
$7.8B
Q1 25
$2.9B
$7.9B
Q4 24
$2.9B
$8.0B
Q3 24
$2.9B
$8.1B
Q2 24
$2.9B
$8.3B
Q1 24
$2.4B
$8.3B
Stockholders' Equity
HRL
HRL
SOLV
SOLV
Q4 25
$7.9B
$5.0B
Q3 25
$8.1B
$5.0B
Q2 25
$8.0B
$3.6B
Q1 25
$8.0B
$3.3B
Q4 24
$8.0B
$3.0B
Q3 24
$7.9B
$3.2B
Q2 24
$7.9B
$2.9B
Q1 24
$7.8B
$3.9B
Total Assets
HRL
HRL
SOLV
SOLV
Q4 25
$13.4B
$14.3B
Q3 25
$13.5B
$14.0B
Q2 25
$13.4B
$15.1B
Q1 25
$13.4B
$14.5B
Q4 24
$13.4B
$14.5B
Q3 24
$13.1B
$14.7B
Q2 24
$14.1B
$14.6B
Q1 24
$13.5B
$14.7B
Debt / Equity
HRL
HRL
SOLV
SOLV
Q4 25
0.36×
1.00×
Q3 25
0.35×
1.03×
Q2 25
0.35×
2.14×
Q1 25
0.36×
2.43×
Q4 24
0.36×
2.71×
Q3 24
0.36×
2.54×
Q2 24
0.36×
2.90×
Q1 24
0.30×
2.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HRL
HRL
SOLV
SOLV
Operating Cash FlowLast quarter
$322.9M
$95.0M
Free Cash FlowOCF − Capex
$231.4M
$32.0M
FCF MarginFCF / Revenue
7.3%
1.6%
Capex IntensityCapex / Revenue
2.9%
3.2%
Cash ConversionOCF / Net Profit
1.51×
TTM Free Cash FlowTrailing 4 quarters
$534.3M
$-10.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HRL
HRL
SOLV
SOLV
Q4 25
$322.9M
$95.0M
Q3 25
$156.7M
$76.0M
Q2 25
$56.4M
$169.0M
Q1 25
$309.2M
$29.0M
Q4 24
$408.6M
$219.0M
Q3 24
$218.0M
$169.0M
Q2 24
$236.1M
$355.0M
Q1 24
$404.0M
$442.0M
Free Cash Flow
HRL
HRL
SOLV
SOLV
Q4 25
$231.4M
$32.0M
Q3 25
$84.5M
$-21.0M
Q2 25
$-18.6M
$59.0M
Q1 25
$237.0M
$-80.0M
Q4 24
$324.8M
$92.0M
Q3 24
$152.5M
$76.0M
Q2 24
$176.2M
$297.0M
Q1 24
$356.8M
$340.0M
FCF Margin
HRL
HRL
SOLV
SOLV
Q4 25
7.3%
1.6%
Q3 25
2.8%
-1.0%
Q2 25
-0.6%
2.7%
Q1 25
7.9%
-3.9%
Q4 24
10.4%
4.4%
Q3 24
5.3%
3.7%
Q2 24
6.1%
14.3%
Q1 24
11.9%
16.9%
Capex Intensity
HRL
HRL
SOLV
SOLV
Q4 25
2.9%
3.2%
Q3 25
2.4%
4.6%
Q2 25
2.6%
5.1%
Q1 25
2.4%
5.3%
Q4 24
2.7%
6.1%
Q3 24
2.3%
4.5%
Q2 24
2.1%
2.8%
Q1 24
1.6%
5.1%
Cash Conversion
HRL
HRL
SOLV
SOLV
Q4 25
1.51×
Q3 25
0.85×
0.06×
Q2 25
0.31×
1.88×
Q1 25
1.81×
0.21×
Q4 24
1.86×
7.06×
Q3 24
1.23×
1.39×
Q2 24
1.25×
3.99×
Q1 24
1.85×
1.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HRL
HRL

Retail Segment$1.9B60%
Foodservice Segment$1.1B34%
Other$174.7M5%

SOLV
SOLV

Infection Prevention And Surgical Solutions$752.0M38%
Cost Of Software And Rentals$508.0M25%
Health Information Systems Segment$347.0M17%
Dental Solutions Segment$343.0M17%
Related Party$14.0M1%

Related Comparisons